Cargando…
Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC)
Vaccination against endothelial cells (ECs) lining the tumor vasculature represents one of the most attractive potential cancer immunotherapy options due to its ability to prevent solid tumor growth. Using this approach, target antigens can be derived from ECs and used to develop a universal cancer...
Autores principales: | Lokhov, Petr G, Balashova, Elena E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514425/ https://www.ncbi.nlm.nih.gov/pubmed/25714389 http://dx.doi.org/10.1080/21645515.2015.1011022 |
Ejemplares similares
-
SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2017) -
SANTAVAC(TM): Summary of Research and Development
por: Lokhov, Petr G., et al.
Publicado: (2019) -
Allogeneic Antigen Composition for Preparing Universal Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2016) -
Antigenic Essence: Upgrade of Cellular Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2021) -
Cellular Cancer Vaccines: an Update on the Development of Vaccines Generated from Cell Surface Antigens
por: Lokhov, Petr G., et al.
Publicado: (2010)